Apollomics (APLM) Other Non-Current Assets (2021 - 2025)

Apollomics (APLM) posted quarterly Other Non-Current Assets of $83000.0 for Q4 2025, up 10.67% year-on-year from $75000.0 in Q4 2024, and up 1.22% on a QoQ basis from $82000.0 in Q2 2025.

Apollomics (APLM) Other Non-Current Assets (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Other Non-Current Assets for 5 consecutive years, with $83000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets rose 10.67% year-over-year to $83000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $83000.0 (up 10.67% YoY) and the FY2025 annual result came in at $83000.0, up 10.67% from the prior year.
  • Other Non-Current Assets rose to $83000.0 in Q4 2025 per APLM's latest filing, from $82000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for APLM reached as high as $124000.0 in Q4 2022 and fell as low as $75000.0 in Q4 2024.
  • A 5-year average of $103500.0 and a median of $113000.0 in 2021 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets sank 36.97% — and 2025, when it increased 10.67%.
  • Year by year, Other Non-Current Assets stood at $113000.0 in 2021, then rose by 9.73% to $124000.0 in 2022, then slipped by 4.03% to $119000.0 in 2023, then plunged by 36.97% to $75000.0 in 2024, then grew by 10.67% to $83000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $83000.0, $82000.0, and $75000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Apollomics 2.66 Bn 2.66 Bn - 83,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 83,000.00
Jun 30, 2025 82,000.00
Dec 31, 2024 75,000.00
Jun 30, 2024 113,000.00
Dec 31, 2023 119,000.00
Jun 30, 2023 119,000.00
Dec 31, 2022 124,000.00
Dec 31, 2021 113,000.00